Ontology highlight
ABSTRACT: Background and objectives
Patients with kidney failure have a high risk of cardiovascular disease due to cardiac remodeling, left ventricular fibrosis, and hyperaldosteronism, all of which can be potentially mitigated by mineralocorticoid receptor antagonists. However, because of the fear of hyperkalemia, the use of mineralocorticoid receptor antagonists in patients with kidney failure is limited in current clinical practice, and few studies have investigated the efficacy and safety. Thus, we aimed to determine the benefits and side effects of mineralocorticoid receptor antagonists in patients with kidney failure treated with dialysis.Design, setting, participants, & measurements
This is a systematic review and meta-analysis of randomized controlled trials published from 20
SUBMITTER: Chen KT
PROVIDER: S-EPMC8216612 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature